Table 3.
Tumor in our patients.
| PID | Number of patients with PID | Number of patients with PID and tumor | Number of tumors | Type of tumor | ||
|---|---|---|---|---|---|---|
| 1° tumor | 2° tumor | 3° tumor | ||||
| CVID | 74 | 8 | 10 | 1 HL | 1 Squamous cell carcinoma in situ | |
| 1 Papillary thyroid cancer | ||||||
| 3 NHL: (1 MALT, 1 Burkitt e 1 diffuse large B cell lymphoma) | ||||||
| 1 Lobular carcinoma of the breast | ||||||
| 1 Gastric NIN | ||||||
| 1 Clear cell renal cell carcinoma | ||||||
| 1 Duodena GIST | ||||||
| CID | 29 | 5 | 8 | 2 HL | 3 NHL: | |
| 2 NHL: (1 linfoblastic T; 1 diffuse large B cell lymphoma) | (2 Diffuse large B cell lymphoma; 1 Mycosis fungoide) | |||||
| 1 Adrenal leiomyosarcoma | ||||||
| SCID | 123 | 1 | 1 | 1 Diffuse large cells lymphoma | ||
| AT | 19 | 3 | 3 | 3 NHL: (2 diffuse large B cell lymphomas; 1 Burkitt) | ||
| XLA | 46 | 2 | 2 | 1 Acute linfobastic leukemia | ||
| 1 Gastric carcinoma | ||||||
| HSP2 | 2 | 2 | 3 | 2 HL | 1Dermatofibroma | |
| HIES | 13 | 2 | 4 | Papillary thyroid cancer | 1 Basalioma | 1 Diffuse large cells lymphoma |
| 1 Anaplastic large cells lymphoma | ||||||
| WAS | 52 | 2 | 2 | 2 NHL: (1 Plasmablastic lymphoma 1 nd) | ||